Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Remicalm logo — Enhancing early detection and effective treatment of various...

Remicalm

Enhancing early detection and effective treatment of various cancers with innovative medical imaging and diagnostic devices for better outcomes.

Founded 2006 United States Houston, United States 1 employees Debt Financing Total: $500.00K Health Care, Manufacturing

General Information

Company Name Remicalm
Founded Year 2006
Location United States Houston, United States +1
Employees 1
Industries Health Care, Manufacturing
Funding Stage Debt Financing
Social

Get notified when Remicalm moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Remicalm

Remicalm, LLC is a medical diagnostic and imaging device company established in 2006 and headquartered in Houston, Texas. The company focuses on designing, manufacturing, and marketing innovative medical devices for cancer diagnostic, screening, imaging, and monitoring within the United States. Their products target imaging and diagnosing various cancers, including oral, cervical, skin, bladder, esophagus, and colon cancers. With a slogan of "Enhancing early detection and effective treatment of various cancers," Remicalm's offerings are geared towards early detection and treatment of cancers and pre-cancers occurring in the cells lining the internal and external surfaces of the body. Notably, the company received a $500.00K debt financing investment on 12 August 2009. The incorporation of innovative medical imaging and diagnostic devices positions Remicalm at the forefront of the health care and manufacturing industries. The company's focus on improving cancer outcomes through early detection aligns with the growing emphasis on preventive healthcare. This could present a compelling opportunity for venture capital investors seeking to support groundbreaking advancements in the medical technology sector.

Taxonomy: medical imaging, diagnostic devices, cancer detection, cancer treatment, early detection, screening devices, imaging devices, cancer diagnostic devices, oncology, cancer monitoring devices, biomedical devices, cancer diagnostics, cancer screening

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 12 Aug 2009

Remicalm Alternatives & Competitors

Remicalm vs
Röntgentekno Oy, Imaqen
Röntgentekno Oy, Imaqen Finland

Towards better imaging - Kohti parempaa kuvantamista

Grant
10 employees
Biotechnology, Health Care
Remicalm vs
Oncohealth CORP
Oncohealth CORP

Pioneering the future of cancer detection with advanced protein bio-markers for comprehensive screen...

Series Unknown
1 employees
Biopharma, Biotechnology
Remicalm vs
Seno Medical
Seno Medical United States

Groundbreaking diagnostic imaging for breast cancer using a novel combination of ultrasound and opto...

Series C
49 employees
Health Care, Medical Devices

FAQ About Remicalm

Enhancing early detection and effective treatment of various cancers with innovative medical imaging and diagnostic devices for better outcomes.
Remicalm was founded in 2006.
Remicalm is headquartered in Houston, United States.
Remicalm operates in the following industries: Health Care, Manufacturing.
Remicalm has approximately 1 employees.
Remicalm has completed 1 funding round, raising a total of $500.00K. The latest funding stage is Debt Financing.
Top alternatives and competitors to Remicalm include Röntgentekno Oy, Imaqen, Oncohealth CORP, Seno Medical, Guerbet, Stork Healthcare. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Remicalm and Röntgentekno Oy, Imaqen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Remicalm and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy